Members |
targetComponentId |
Overexposure to radiation NOS |
Overexposure to radiation (event) |
Overexposure to radioactive isotope NOS |
Overexposure to radioactive isotopes |
Overexposure to radiofrequency radiation NOS |
Overexposure to radiofrequency radiation (event) |
hypertrofisk granulation fra operationssår med sekundær heling |
Over-granulating secondary intention surgical wound (finding) |
malignt neoplasme i mamma hos kvinde overgribende flere regioner |
Malignant neoplasm of overlapping sites of breast (disorder) |
malignt neoplasme med dårligt definerede lokalisation, overgribende flere områder |
Malignant neoplastic disease (disorder) |
malignt neoplasme i mamma hos mand overgribende flere regioner |
Malignant neoplasm of overlapping sites of breast (disorder) |
Overriding right ventriculoarterial valve |
Pulmonary valve overriding ventricular septum (disorder) |
Ovis musimon |
Ovis aries |
Ovotestis |
Ovotesticular disorder of sex development |
ovula Nabothi |
Retention cyst |
Ovulation temp. chart NOS |
Ovulation temperature chart started |
Ovulation temp. chart NOS |
Ovulation test temperature chart (procedure) |
oxacillinnatrium 250 mg/5 ml pulver til oral opløsning |
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Oxford Knee Score version 1.0 score |
Oxford Knee Score using revised scoring system (observable entity) |
Oxidase |
Oxidase |
Oxo-acid-lyase |
Oxo-acid-lyase |
Oxybuprocaine 0.4% eye drops |
Oxybuprocaine only product |
Oxybuprocaine hydrochloride 0.4% conventional release eye drops |
Oxybuprocaine only product |
Oxybuprokain-øjendråber 0,4%, enkeltdosisbeholder |
Oxybuprocaine only product |
oxybutynin 3,9 mg/dag transdermalt system |
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
oxybutyninhydrochlorid 15 mg tablet med modificeret udløsning |
Oxybutynin only product in oral dose form |
Oxybutynin hydrochloride 15mg prolonged-release oral tablet |
Oxybutynin only product in oral dose form |
oxycodonhydrochlorid 160 mg tablet med modificeret udløsning |
Product containing only oxycodone in oral dose form (medicinal product form) |
Oxycodone hydrochloride 160mg prolonged-release oral tablet |
Product containing only oxycodone in oral dose form (medicinal product form) |
Oxygen enrichment therapy NOS |
Oxygen enrichment therapy |
Oxygen enrichment therapy nos |
Oxygen enrichment therapy |
forhøjelse af SaO2 |
Oxygen saturation above reference range |
Oxygenase |
Oxygenase |
Oxymetazoline hydrochloride 0.025% nose drops |
Oxymetazoline hydrochloride 250 microgram/mL nasal solution |
oxymetazolinhydrochlorid 0,05 % øjendråber |
Oxymetazoline hydrochloride 500 microgram/mL eye solution |
Oxymetazoline hydrochloride 0.05% nose drops |
Oxymetazoline hydrochloride 500 microgram/mL nasal solution |
oxymorphon 10 mg tablet med modificeret udløsning |
Oxymorphone only product in oral dose form |
Oxymorphone 10mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
oxymorphon 20 mg tablet med modificeret udløsning |
Oxymorphone only product in oral dose form |
Oxymorphone 20mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
oxymorphon 40 mg tablet med modificeret udløsning |
Oxymorphone only product in oral dose form |
Oxymorphone 40mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
oxymorphon 5 mg tablet med modificeret udløsning |
Oxymorphone only product in oral dose form |
Oxymorphone 5mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
oxytocin 10 enheder infusionsvæske, opløsning, hætteglas a 1 ml |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
Oyster - dietary |
Oyster (substance) |
P.M. isolation: organism NOS |
P.M. isolation: organism - finding |
PEG-intron redipen |
Product containing peginterferon alfa-2b (medicinal product) |
PEG-intron redipen 120 µg pulver + 0,5 ml sterilt vand |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
PEG-intron redipen 150 µg pulver + 0,5 ml sterilt vand |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
PEG-intron redipen 50 µg pulver + 0,5 ml sterilt vand |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
PEG-intron redipen 80 µg pulver + 0,5 ml sterilt vand |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
PIE syndrome |
Simple pulmonary eosinophilia |
Packager/labeller NOS |
Packagers/labellers |
Packager/labeller NOS |
Packagers/labellers |
Packing - action |
To put in between or into a part(s) of the body. |
paclitaxel 1 µg/mm lægemiddeleluerende stent |
Paclitaxel 1 microgram/mm2 drug eluting stent (product) |
Pain character NOS |
Pain character - finding |
Pain character NOS |
Pain character |
Pain in limb &/or NOS |
Pain in limb |
Pain in limb &/or NOS |
Pain in limb |
Pain in limb NOS |
Pain in limb |
Smerte i arm eller ben, ikke nærmere specificeret |
Pain in limb |
Smerter i mundhulen |
Pain of region of internal part of mouth (finding) |
Painful ejaculation |
Painful ejaculation |
Painter/coater NOS |
Painters/coaters |
Painter/coater NOS |
Painters/coaters |
pensling af vorter på kvindelige perineum |
Painting of perineal warts (procedure) |
Palatal flap |
Flap (substance) |
Palatoplasty |
Uvulopalatopharyngoplasty |
Pale faeces |
Pale feces |
Pale faeces |
Pale feces |
Bleg afføring, symptom |
Pale feces |
blegrød farve |
Pale red colour |
Hjertebanken, ikke nærmere specificeret |
Palpitations |
Palpitations NOS |
Palpitations |
dinatriumpamidronat 3 mg/ml infusionskoncentrat, hætteglas a 5 ml |
Product containing precisely disodium pamidronate 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Pancreas excision |
Pancreatectomy |
Pancreas operations NOS |
Operation on pancreas |
Operationer på pancreas, ikke nærmere specificeret |
Operation on pancreas |
Pancreatectomy NEC |
Pancreatectomy |
Pankreatektomi, ikke klassificeret andetsteds |
Pancreatectomy |
pancrelipase, amylase:lipase 183,49 mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 184,84 mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 210,33 mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 278,72 %mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 312,17 mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 346,86 mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 4500 enheder kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 62,81 % |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 62,81 % kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
pancrelipase, amylase:lipase 94,3 mg kapsel |
Amylase and pancrelipase and triacylglycerol lipase only product |
Pantoprazole sodium 40mg injection |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
Pantoprazole sodium 40mg m/r tablet |
Pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant oral tablet |
Pantoprazole sodium 40mg powder |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
Pantoprazole sodium 40mg/vial powder for injection |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
papainspecifikt ekstrakt |
Product containing papain (medicinal product) |
Papaya - dietary |
Papaya |
Paper/board processor NOS |
Paper and board processor |
Paper/board processor NOS |
Paper and board processor |
Paphosia adorabilis |
Lophornis adorabilis (organism) |
Papillary cystadenoma, borderline malignancy |
Papillary cystadenoma, borderline malignancy |
Papillary cystic tumour |
Primary malignant solid pseudopapillary neoplasm of pancreas (disorder) |
Papillary mucinous cystadenoma, borderline malignancy |
Papillary mucinous cystadenoma, borderline malignancy (morphologic abnormality) |
Papillært serøst cystadenokarcinom |
Serous cystadenocarcinoma |